| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.4B | $0.3B | $0.3B | $0.4B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $6.02 | $5.21 | $3.90 | $5.01 | $5.43 | $1.36 | $0.88 | $0.92 |
| EPS (Diluted) | $6.00 | $5.19 | $3.89 | $4.99 | $5.40 | $1.36 | $0.88 | $0.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.5B | $26.3B | $25.2B | $25.1B | $23.9B | $20.4B | $18.2B | $11.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $23.4B | $22.5B | $21.8B | $21.9B | $20.9B | $17.8B | $15.8B | $10.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.1B | $3.8B | $3.4B | $3.2B | $3.0B | $2.6B | $2.5B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.2B | $0.6B | $1.1B | $0.0B | $0.8B | $-0.9B | $-0.1B |
| Investing Cash Flow | $-1.3B | $-0.8B | $-0.3B | $-4.9B | $-0.4B | $-1.2B | $-0.5B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.8B | $0.7B | $-0.2B | $0.9B | $2.4B | $1.9B | $1.4B | $0.5B |